Literature DB >> 22130669

Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells.

Izabela Sokolowska1, Alisa G Woods, Mary Ann Gawinowicz, Urmi Roy, Costel C Darie.   

Abstract

Tumor differentiation factor (TDF) is a recently discovered protein, produced by the pituitary gland and secreted into the bloodstream. TDF and TDF-P1, a 20-amino acid peptide selected from the open reading frame of TDF, induce differentiation in human breast and prostate cancer cells but not in other cells. TDF protein has no identified site of action or receptor, and its mechanism of action is unknown. Here, we used TDF-P1 to purify and identify potential TDF receptor (TDF-R) candidates from MCF7 steroid-responsive breast cancer cells and non-breast HeLa cancerous cells using affinity purification chromatography (AP), and mass spectrometry (MS). We identified four candidate proteins from the 70-kDa heat shock protein (HSP70) family in MCF7 cells. Experiments in non-breast HeLa cancerous cells did not identify any TDF-R candidates. AP and MS experiments were validated by AP and Western blotting (WB). We additionally looked for TDF-R in steroid-resistant BT-549 cells and human dermal fibroblasts (HDF-a) using AP and WB. TDF-P1 interacts with potential TDF-R candidates from MCF7 and BT-549 breast cells but not from HeLa or HDF-a cells. Immunofluorescence (IF) experiments identified GRP78, a TDF-R candidate, at the cell surface of MCF7, BT-549 breast cells, and HeLa cells but not HDF-a cells. IF of other HSP70 proteins demonstrated labeling on all four cell types. These results point toward GRP78 and HSP70 proteins as strong TDF-R candidates and suggest that TDF interacts with its receptor, exclusively on breast cells, through a steroid-independent pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130669      PMCID: PMC3265855          DOI: 10.1074/jbc.M111.284091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

Review 1.  Roles of GRP78 in physiology and cancer.

Authors:  Lu-Hua Zhang; Xiang Zhang
Journal:  J Cell Biochem       Date:  2010-08-15       Impact factor: 4.429

2.  The critical role of GRP78 in physiologic and pathologic stress.

Authors:  Kyle T Pfaffenbach; Amy S Lee
Journal:  Curr Opin Cell Biol       Date:  2010-10-21       Impact factor: 8.382

3.  Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen.

Authors:  Uma K Misra; Sturgis Payne; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

4.  Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP.

Authors:  Yi Zhang; Ren Liu; Min Ni; Parkash Gill; Amy S Lee
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

5.  Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78.

Authors:  Yasufumi Katanasaka; Takayuki Ishii; Tomohiro Asai; Hirotaka Naitou; Noriyuki Maeda; Fumiaki Koizumi; Shinichi Miyagawa; Norio Ohashi; Naoto Oku
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

6.  Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathways.

Authors:  Lu-Hua Zhang; Xiao-Liang Yang; Xiang Zhang; Jin-Xiang Cheng; Wei Zhang
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

7.  Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores.

Authors:  Ali A Al-Hashimi; Jennifer Caldwell; Mario Gonzalez-Gronow; Salvatore V Pizzo; Danya Aboumrad; Lindsay Pozza; Hiam Al-Bayati; Jeffrey I Weitz; Alan Stafford; Howard Chan; Anil Kapoor; Donald W Jacobsen; Jeffrey G Dickhout; Richard C Austin
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

Review 8.  GRP78 signaling hub a receptor for targeted tumor therapy.

Authors:  Masanori Sato; Virginia J Yao; Wadih Arap; Renata Pasqualini
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 9.  Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting.

Authors:  Min Ni; Yi Zhang; Amy S Lee
Journal:  Biochem J       Date:  2011-03-01       Impact factor: 3.857

10.  Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity.

Authors:  Alba T Macias; Douglas S Williamson; Nicola Allen; Jenifer Borgognoni; Alexandra Clay; Zoe Daniels; Pawel Dokurno; Martin J Drysdale; Geraint L Francis; Christopher J Graham; Rob Howes; Natalia Matassova; James B Murray; Rachel Parsons; Terry Shaw; Allan E Surgenor; Lindsey Terry; Yikang Wang; Mike Wood; Andrew J Massey
Journal:  J Med Chem       Date:  2011-05-20       Impact factor: 7.446

View more
  19 in total

1.  Identification of a novel TPM4 isoform transcript and comparison to the expression of other tropomyosin isoforms in bovine cardiac and skeletal muscles.

Authors:  Syamalima Dube; Lynn Abbott; Samender Randhawa; Yingli Fan; Joseph W Sanger; Jean M Sanger; Bernard J Poiesz; Dipak K Dube
Journal:  Int J Biochem Mol Biol       Date:  2021-02-15

Review 2.  Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches.

Authors:  Armand G Ngounou Wetie; Izabela Sokolowska; Alisa G Woods; Urmi Roy; Katrin Deinhardt; Costel C Darie
Journal:  Cell Mol Life Sci       Date:  2013-04-12       Impact factor: 9.261

Review 3.  Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).

Authors:  Izabela Sokolowska; Alisa G Woods; Mary Ann Gawinowicz; Urmi Roy; Costel C Darie
Journal:  Cell Mol Life Sci       Date:  2012-10-18       Impact factor: 9.261

4.  Mass spectrometry-based proteomics of oxidative stress: Identification of 4-hydroxy-2-nonenal (HNE) adducts of amino acids using lysozyme and bovine serum albumin as model proteins.

Authors:  Roshanak Aslebagh; Bruce A Pfeffer; Steven J Fliesler; Costel C Darie
Journal:  Electrophoresis       Date:  2016-06-07       Impact factor: 3.535

5.  Structural evaluation and analyses of tumor differentiation factor.

Authors:  Urmi Roy; Alisa G Woods; Izabela Sokolowska; Costel C Darie
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

6.  Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity.

Authors:  Britta Hardy; Annat Raiter; Maxim Yakimov; Alexander Vilkin; Yaron Niv
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

Review 7.  Investigation of stable and transient protein-protein interactions: Past, present, and future.

Authors:  Armand G Ngounou Wetie; Izabela Sokolowska; Alisa G Woods; Urmi Roy; Joseph A Loo; Costel C Darie
Journal:  Proteomics       Date:  2013-01-18       Impact factor: 3.984

8.  Proteomic analysis of plasma membranes isolated from undifferentiated and differentiated HepaRG cells.

Authors:  Izabela Sokolowska; Cristina Dorobantu; Alisa G Woods; Alina Macovei; Norica Branza-Nichita; Costel C Darie
Journal:  Proteome Sci       Date:  2012-08-02       Impact factor: 2.480

9.  Comparative proteomics reveals novel components at the plasma membrane of differentiated HepaRG cells and different distribution in hepatocyte- and biliary-like cells.

Authors:  Catalina Petrareanu; Alina Macovei; Izabela Sokolowska; Alisa G Woods; Catalin Lazar; Gabriel L Radu; Costel C Darie; Norica Branza-Nichita
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

10.  GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids.

Authors:  Anna A Birukova; Patrick A Singleton; Grzegorz Gawlak; Xinyong Tian; Tamara Mirzapoiazova; Bolot Mambetsariev; Oleksii Dubrovskyi; Olga V Oskolkova; Valery N Bochkov; Konstantin G Birukov
Journal:  Mol Biol Cell       Date:  2014-05-14       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.